OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long Noncoding RNAs in Taxane Resistance of Breast Cancer
Hailong Chen, Mengwen Zhang, Yongchuan Deng
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12253-12253
Open Access | Times Cited: 8
Hailong Chen, Mengwen Zhang, Yongchuan Deng
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12253-12253
Open Access | Times Cited: 8
Showing 8 citing articles:
Mechanisms behind the LncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies
Ali G. Alkhathami, Harikumar Pallathadka, Sejal Shah, et al.
Experimental Cell Research (2025), pp. 114434-114434
Closed Access
Ali G. Alkhathami, Harikumar Pallathadka, Sejal Shah, et al.
Experimental Cell Research (2025), pp. 114434-114434
Closed Access
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 3
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 3
Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer
Peng Xue, Lisi Ma, Xuan Chen, et al.
Oncology Reports (2024) Vol. 52, Iss. 2
Open Access | Times Cited: 3
Peng Xue, Lisi Ma, Xuan Chen, et al.
Oncology Reports (2024) Vol. 52, Iss. 2
Open Access | Times Cited: 3
Non-Coding RNA as a Biomarker in Lung Cancer
C. Raman Suri, Shashikant Swarnkar, L.V.K.S. Bhaskar, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 5, pp. 50-50
Open Access | Times Cited: 3
C. Raman Suri, Shashikant Swarnkar, L.V.K.S. Bhaskar, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 5, pp. 50-50
Open Access | Times Cited: 3
Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus /rapidly accelerated fibrosarcoma 1 pathway
Tong Zhu, Peng Zhou, Lu Yang, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 4, pp. 2064-2076
Closed Access | Times Cited: 2
Tong Zhu, Peng Zhou, Lu Yang, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 4, pp. 2064-2076
Closed Access | Times Cited: 2
Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer
Peng Xue, Lisi Ma, Xuan Chen, et al.
Research Square (Research Square) (2024)
Open Access
Peng Xue, Lisi Ma, Xuan Chen, et al.
Research Square (Research Square) (2024)
Open Access
RNA biomarkers in cancer therapeutics: The promise of personalized oncology
Hector Katifelis, Maria Gazouli
Advances in clinical chemistry (2024), pp. 179-219
Closed Access
Hector Katifelis, Maria Gazouli
Advances in clinical chemistry (2024), pp. 179-219
Closed Access
Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway
Huahui Zeng, Xiaohu Zeng, Can Wang, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Huahui Zeng, Xiaohu Zeng, Can Wang, et al.
Drug Delivery and Translational Research (2024)
Closed Access
